 REDWOOD CITY, Calif., Dec. 02, 2020 GLOBE NEWSWIRE -- Codexis, Inc. Nasdaq:CDXS, a leading protein engineering company, today announced the pricing of an underwritten public offering of 4,285,715 shares of its common stock at a public offering price of 17.50 per share. Net proceeds to Codexis from the offering are expected to be approximately 70.2 million after underwriting discounts and commissions and estimated offering expenses. The offering is expected to close on or about December 7, 2020, subject to customary closing conditions. Codexis has granted the underwriters of the offering the right for a period of 30 days to purchase up to an additional 642,857 shares of common stock at the public offering price, less underwriting discounts and commissions. 